Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors
Authors:
- Ryan J. CorbettRCRyan J. Corbett
- Rebecca S. KaufmanRKRebecca S. Kaufman
- Shelly W. McQuaidSMShelly W. McQuaid
- Zalman VaksmanZVZalman Vaksman
- Saksham PhulSPSaksham Phul
- Miguel A. BrownMBMiguel A. Brown
- Jennifer L. MasonJMJennifer L. Mason
- Sebastian M. WaszakSWSebastian M. Waszak
- Chuwei ZhongCZChuwei Zhong
- Emily BlauelEBEmily Blauel
Preprint
Abstract
The contribution of rare pathogenic/likely pathogenic (P/LP) germline variants to pediatric central nervous system (CNS) tumor development remains understudied. Here, we characterized the prevalence and clinical significance of germline P/LP variants in cancer predisposition genes across 830 CNS tumor patients from the Pediatric Brain Tumor Atlas (PBTA). We identified germline P/LP variants in 23.3% (193/830) of patients and the majority (137/193) lacked clinical reporting of genetic tumor syndromes. Among P/LP carriers, 34.6% had putative somatic second hits or loss of function tumor alterations. Finally, we linked pathogenic germline variation with novel somatic events and patient survival to highlight the impact of germline variation on tumorigenesis and patient outcomes.Keywords
This publication has 69 references indexed in Scilit:
- Analysis of 200 unrelated individuals with a constitutional NF1 deep intronic pathogenic variant reveals that variants flanking the alternatively spliced NF1 exon 31 [23a] cause a classical neurofibromatosis type 1 phenotype while altering predominantly NF1 isoform type IIHuman Genetics, 2023
- Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1American Journal of Medical Genetics Part A, 2021
- Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaJAMA Oncology, 2020
- Exosomal miR‐423‐5p targets SUFU to promote cancer growth and metastasis and serves as a novel marker for gastric cancerMolecular Carcinogenesis, 2018
- Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid TumorsJAMA Oncology, 2016
- Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in YouthJAMA, 2015
- ggplot2WIREs Computational Statistics, 2011
- Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOHHuman Mutation, 2010
- Update on the management of familial central nervous system tumor syndromesCurrent Neurology and Neuroscience Reports, 2007
- Modeling Survival Data: Extending the Cox Model2000